BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million

  May 10, 2026

   · 

  3 min read
• Press Releases

  Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

  May 10, 2026

   · 

  5 min read
• Press Releases

  Major Shareholder Announcement - May 8, 2026

  May 10, 2026

   · 

  3 min read
• Press Releases

  Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

  May 10, 2026

   · 

  8 min read
• Press Releases

  Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

  May 10, 2026

   · 

  10 min read
• Press Releases

  Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

  May 10, 2026

   · 

  11 min read
• Press Releases

  Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 8, 2026

  May 10, 2026

   · 

  3 min read
• Press Releases

  FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics

  May 10, 2026

   · 

  2 min read
• Press Releases

  vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 8, 2026

  May 10, 2026

   · 

  2 min read
• Press Releases

  Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 8, 2026

  May 10, 2026

   · 

  2 min read